Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drug Safety
Metadata
Title
Drug Interactions of HIV Protease Inhibitors
Authors
Lisa I. Malaty
Dr Jeffrey J. Kuper
Publication date
01-02-1999
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 2/1999
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199920020-00005

Other articles of this Issue 2/1999

Drug Safety 2/1999 Go to the issue

Review Article

A Risk-Benefit Assessment of Anti-Obesity Drugs

Review Article

Comparative Tolerability and Efficacy of Treatments for Impotence

Practical Drug Safety

Managing Antipsychotic-Induced Tardive Dyskinesia

Current Opinion

The Internet and Drug Safety

Original Research Article

Safety Profile of Lansoprazole

Review Article

Treatment of Anxiety During Pregnancy